GGrantIndex
← Search

ACTG 5025--HYDROXYUREA IN POTENT ANTIRETROVIRAL THERAPY

$0M01FY2002RRNIH

Beth Israel Deaconess Medical Center, Boston MA

Investigators

Linked publications & trials

View original record on NIH RePORTER →
ACTG 5025--HYDROXYUREA IN POTENT ANTIRETROVIRAL THERAPY · GrantIndex